Compare J.B.Chemicals with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs TTK HEALTHCARE - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS TTK HEALTHCARE J.B.CHEMICALS/
TTK HEALTHCARE
 
P/E (TTM) x 22.3 19.0 117.5% View Chart
P/BV x 4.0 1.3 315.5% View Chart
Dividend Yield % 0.3 1.2 24.1%  

Financials

 J.B.CHEMICALS   TTK HEALTHCARE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
TTK HEALTHCARE
Mar-19
J.B.CHEMICALS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3631,215 29.9%   
Low Rs255610 41.8%   
Sales per share (Unadj.) Rs169.1444.4 38.1%  
Earnings per share (Unadj.) Rs16.617.2 96.2%  
Cash flow per share (Unadj.) Rs23.427.6 84.8%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.60.5 118.1%  
Book value per share (Unadj.) Rs172.5177.9 96.9%  
Shares outstanding (eoy) m83.5714.13 591.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.1 89.0%   
Avg P/E ratio x18.652.9 35.2%  
P/CF ratio (eoy) x13.233.0 40.0%  
Price / Book Value ratio x1.85.1 34.9%  
Dividend payout %12.029.0 41.6%   
Avg Mkt Cap Rs m25,82712,894 200.3%   
No. of employees `0003.82.3 163.1%   
Total wages/salary Rs m2,5111,307 192.1%   
Avg. sales/employee Rs Th3,747.42,715.7 138.0%   
Avg. wages/employee Rs Th665.7565.3 117.8%   
Avg. net profit/employee Rs Th367.8105.4 348.9%   
INCOME DATA
Net Sales Rs m14,1356,279 225.1%  
Other income Rs m36678 472.0%   
Total revenues Rs m14,5016,356 228.1%   
Gross profit Rs m2,178496 439.5%  
Depreciation Rs m570147 388.3%   
Interest Rs m3534 103.3%   
Profit before tax Rs m1,940393 494.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m552149 370.9%   
Profit after tax Rs m1,387244 569.2%  
Gross profit margin %15.47.9 195.2%  
Effective tax rate %28.537.9 75.1%   
Net profit margin %9.83.9 252.8%  
BALANCE SHEET DATA
Current assets Rs m10,4702,717 385.3%   
Current liabilities Rs m2,7491,571 175.0%   
Net working cap to sales %54.618.3 299.2%  
Current ratio x3.81.7 220.2%  
Inventory Days Days5532 171.6%  
Debtors Days Days7847 166.5%  
Net fixed assets Rs m5,811991 586.4%   
Share capital Rs m167141 118.3%   
"Free" reserves Rs m14,2482,373 600.4%   
Net worth Rs m14,4162,514 573.3%   
Long term debt Rs m03 0.0%   
Total assets Rs m17,6494,158 424.4%  
Interest coverage x56.612.6 448.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.81.5 53.0%   
Return on assets %8.16.7 120.7%  
Return on equity %9.69.7 99.3%  
Return on capital %13.716.9 80.9%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m6,164225 2,737.1%   
Fx outflow Rs m1,33471 1,876.6%   
Net fx Rs m4,829154 3,134.2%   
CASH FLOW
From Operations Rs m1,231173 710.9%  
From Investments Rs m-20897 -215.6%  
From Financial Activity Rs m-595-307 193.7%  
Net Cashflow Rs m427-38 -1,132.9%  

Share Holding

Indian Promoters % 55.4 65.4 84.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 3.7 91.6%  
FIIs % 3.9 5.2 75.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.8 143.4%  
Shareholders   30,437 12,723 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

India's Q4 GDP Numbers and Takeaways, March Quarter Results, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended on a positive note on Friday. It was the third day benchmark indices edged higher tracking mixed cues from global markets.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 29, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - VENUS REMEDIES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS